ABP
Price
$1.04
Change
-$0.08 (-7.14%)
Updated
Jan 30, 04:59 PM (EDT)
Capitalization
58.03M
CVM
Price
$0.39
Change
-$0.01 (-2.50%)
Updated
Jan 31, 10:40 AM (EDT)
Capitalization
28.56M
13 days until earnings call
Ad is loading...

ABP vs CVM

Header iconABP vs CVM Comparison
Open Charts ABP vs CVMBanner chart's image
Abpro Holdings
Price$1.04
Change-$0.08 (-7.14%)
Volume$4.4K
Capitalization58.03M
Cel-Sci
Price$0.39
Change-$0.01 (-2.50%)
Volume$700
Capitalization28.56M
ABP vs CVM Comparison Chart
Loading...
ABP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABP vs. CVM commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABP is a StrongBuy and CVM is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 31, 2025
Stock price -- (ABP: $1.03 vs. CVM: $0.40)
Brand notoriety: ABP: Not notable vs. CVM: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABP: 6% vs. CVM: 16%
Market capitalization -- ABP: $58.03M vs. CVM: $28.56M
ABP [@Biotechnology] is valued at $58.03M. CVM’s [@Biotechnology] market capitalization is $28.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $379.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2.47B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABP’s FA Score shows that 0 FA rating(s) are green whileCVM’s FA Score has 0 green FA rating(s).

  • ABP’s FA Score: 0 green, 5 red.
  • CVM’s FA Score: 0 green, 5 red.
According to our system of comparison, CVM is a better buy in the long-term than ABP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABP’s TA Score shows that 1 TA indicator(s) are bullish while CVM’s TA Score has 3 bullish TA indicator(s).

  • ABP’s TA Score: 1 bullish, 2 bearish.
  • CVM’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ABP is a better buy in the short-term than CVM.

Price Growth

ABP (@Biotechnology) experienced а -19.53% price change this week, while CVM (@Biotechnology) price change was +2.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.14%. For the same industry, the average monthly price growth was +1.50%, and the average quarterly price growth was +5.12%.

Reported Earning Dates

CVM is expected to report earnings on Feb 13, 2025.

Industries' Descriptions

@Biotechnology (-1.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABP($58M) has a higher market cap than CVM($28.6M). CVM YTD gains are higher at: -0.100 vs. ABP (-42.458). ABP has higher annual earnings (EBITDA): -17.4M vs. CVM (-23.71M). CVM has more cash in the bank: 385K vs. ABP (13.6K). ABP has less debt than CVM: ABP (160K) vs CVM (12.1M). ABP has higher revenues than CVM: ABP (122K) vs CVM (0).
ABPCVMABP / CVM
Capitalization58M28.6M203%
EBITDA-17.4M-23.71M73%
Gain YTD-42.458-0.10042,450%
P/E RatioN/AN/A-
Revenue122K0-
Total Cash13.6K385K4%
Total Debt160K12.1M1%
FUNDAMENTALS RATINGS
CVM: Fundamental Ratings
CVM
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
57
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABPCVM
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 24 days ago
43%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 24 days ago
8%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 24 days ago
17%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 24 days ago
20%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
Bearish Trend 30 days ago
38%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
ABP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INSE10.020.35
+3.62%
Inspired Entertainment
QNTM3.020.08
+2.72%
Quantum Biopharma Ltd
BCE23.900.20
+0.84%
BCE
LQDT37.300.27
+0.73%
Liquidity Services
LNTH92.790.26
+0.28%
Lantheus Holdings

ABP and

Correlation & Price change

A.I.dvisor tells us that ABP and CVM have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ABP and CVM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABP
1D Price
Change %
ABP100%
-8.04%
CVM - ABP
32%
Poorly correlated
+3.66%
QSI - ABP
29%
Poorly correlated
-3.92%
NGNE - ABP
28%
Poorly correlated
+0.13%
PHAT - ABP
27%
Poorly correlated
-3.21%
TRAW - ABP
26%
Poorly correlated
-1.22%
More

CVM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CVM has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CVM jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVM
1D Price
Change %
CVM100%
+3.66%
MDGL - CVM
43%
Loosely correlated
+3.66%
CYTK - CVM
40%
Loosely correlated
+2.71%
ADXN - CVM
39%
Loosely correlated
-3.31%
EYPT - CVM
38%
Loosely correlated
+4.14%
ABP - CVM
32%
Poorly correlated
-8.04%
More